
Swiss Medisciences Private Limited
Founded in 2024 and headquartered in Karnataka, India.
Founded in 2024 and headquartered in Karnataka, India.
Swiss Medisciences Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 December 2024 ( two months 23 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vishal Pipada and Svinay serve as directors at the Company.
Bangaluru, Karnataka, India
+91-XXXXXXXXXX
U46497KA2024PTC196079
196079
Private Limited Indian Non-Government Company
20 Dec 2024
-
-
Unlisted
Roc Bangalore
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vishal Pipada ![]() | Director | 20-Dec-2024 | Current |
Svinay ![]() | Director | 20-Dec-2024 | Current |
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Swiss Medisciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Vishal Pipada is a mutual person
Vishal Pipada and Svinay are mutual person
Vishal Pipada is a mutual person
Vishal Pipada is a mutual person
Svinay is a mutual person
Svinay is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Swiss Medisciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Swiss Medisciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swiss Medisciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Vishal Subhas Chand Pipada was appointed as a Director was appointed as a Director on 20 Dec 2024 & has been associated with this company since 2 months 23 days .
Svinay was appointed as a Director was appointed as a Director on 20 Dec 2024 & has been associated with this company since 2 months 23 days .
Swiss Medisciences Private Limited was registered on 20 Dec 2024 with Roc Bangalore & aged 2 months 23 days as per MCA records.
Swiss Medisciences Private Limited was incorporated on 20 Dec 2024.
The authorized share capital of Swiss Medisciences Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Swiss Medisciences Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Swiss Medisciences Private Limited is 1685 3Rd Main Road Rammohanpuram, Rajajinaga India, Bangalore North, Karnataka, 560021.
The corporate identification number (CIN) of Swiss Medisciences Private Limited is U46497KA2024PTC196079 and the company number is 196079 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.